• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Cell Rep . Fortuitous somatic mutations during antibody evolution endow broad neutralization against SARS-CoV-2 Omicron variants

tetano

Editor, Senior Moderator
Cell Rep


. 2023 May 3;42(5):112503.
doi: 10.1016/j.celrep.2023.112503. Online ahead of print. Fortuitous somatic mutations during antibody evolution endow broad neutralization against SARS-CoV-2 Omicron variants

Jianbo Wu[SUP] 1 [/SUP], Zhenguo Chen[SUP] 1 [/SUP], Yidan Gao[SUP] 1 [/SUP], Zegen Wang[SUP] 2 [/SUP], Jiarong Wang[SUP] 2 [/SUP], Bing-Yu Chiang[SUP] 2 [/SUP], Yunjiao Zhou[SUP] 3 [/SUP], Yuru Han[SUP] 1 [/SUP], Wuqiang Zhan[SUP] 1 [/SUP], Minxiang Xie[SUP] 1 [/SUP], Weiyu Jiang[SUP] 1 [/SUP], Xiang Zhang[SUP] 1 [/SUP], Aihua Hao[SUP] 1 [/SUP], Anqi Xia[SUP] 1 [/SUP], Jiaying He[SUP] 1 [/SUP], Song Xue[SUP] 1 [/SUP], Christian T Mayer[SUP] 4 [/SUP], Fan Wu[SUP] 1 [/SUP], Bin Wang[SUP] 5 [/SUP], Lunan Zhang[SUP] 6 [/SUP], Lei Sun[SUP] 7 [/SUP], Qiao Wang[SUP] 8 [/SUP]



Affiliations
Abstract

Striking antibody evasion by emerging circulating severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variants drives the identification of broadly neutralizing antibodies (bNAbs). However, how a bNAb acquires increased neutralization breadth during antibody evolution is still elusive. Here, we identify a clonally related antibody family from a convalescent individual. One of the members, XG005, exhibits potent and broad neutralizing activities against SARS-CoV-2 variants, while the other members show significant reductions in neutralization breadth and potency, especially against the Omicron sublineages. Structural analysis visualizing the XG005-Omicron spike binding interface reveals how crucial somatic mutations endow XG005 with greater neutralization potency and breadth. A single administration of XG005 with extended half-life, reduced antibody-dependent enhancement (ADE) effect, and increased antibody product quality exhibits a high therapeutic efficacy in BA.2- and BA.5-challenged mice. Our results provide a natural example to show the importance of somatic hypermutation during antibody evolution for SARS-CoV-2 neutralization breadth and potency.

Keywords: CP: Immunology; CP: Microbiology; SARS-CoV-2; bNAb; broadly neutralizing antibody; clonally related antibody family; somatic hypermutation; variant of concern.

 
Back
Top Bottom